25 results
·
27ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Catheter, Coronary, Atherectomy
FDA Pre-Market Approval
FDA Class 3
·SIMPSON CORONARY ATHEROCATH-GTO
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx
Heart-Valve, Mechanical
FDA Pre-Market Approval
FDA Class 3
·ST. JUDE MEDICAL MECHANICAL HEART VALVE
Absorbable Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM
Absorbable Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM
Absorbable Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·Absorb GTi Bioresorbable Vascular Scaffold (BVS) System
Absorbable Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·Absorb GT1 Bioresorbable Vascular Scaffold (BVS) System
Catheter, Coronary, Atherectomy
FDA Pre-Market Approval
FDA Class 3
·SIMPSON CORONARY ATHEROCATH(R) (GTO)(TM) DEVICE
Absorbable Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM
Absorbable Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·Absorb GT1 Bioresorbable Vascular Scaffold (BVS) System.
Absorbable Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM
Absorbable Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM
Absorbable Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·Absorb GT1 Bioresorbable Vascular Scaffold (BVS) System
Absorbable Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM
Catheter, Coronary, Atherectomy
FDA Pre-Market Approval
FDA Class 3
·SIMPSON CORONARY ATHEROCATH-SCA-EX, GTO AND BANTAM ATHERECTOMY CATHETERS
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx
Catheter, Coronary, Atherectomy
FDA Pre-Market Approval
FDA Class 3
·SIMPSON CORONARY ATHEROCATH(TM),SCA-EX(TM), SCA-EX 7 FRENCH GRAFT AND ATHEROCATH-GTO(R)
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 PharmDx